The effect of podiatric treatment on individuals with generalized joint hypermobility and Ehlers-Danlos syndrome

30 OCT

The effect of podiatric treatment on individuals with generalized joint hypermobility and Ehlers-Danlos syndrome

Join us for this 40-minute presentation and 10-minute Q&A session on the topic of The effect of podiatric treatment on individuals with generalized joint hypermobility and Ehlers-Danlos syndrome.

In this webinar, Sports Podiatrist Muhammad (Mo) Maarj will provide a brief overview of the misunderstandings surrounding hypermobility terminology and provide an update on the latest diagnosis standards for paediatric patients. Mo will also deep dive into an examination of podiatry studies and ways to expand upon them as well as providing practical podiatry advice for supporting patients with Generalized Joint Hypermobility (GJH) and Ehlers-Danlos Syndrome (EDS).

Learning Objectives:

1. What is a podiatrist role in managing GJH and EDS
2. Podiatric advice for managing patients with GJH and EDS
3. Examine existing literature into hypermobility in paediatric patients

The Presenter:

Muhammad (Mo) Maarj
BPod PhD Candidate, Sports Podiatrist, Chair of Australian Paediatric group

Mo is a consultant sports podiatrist at Narrabeen Sports Medicine Centre, where he focuses on chronic musculoskeletal injuries. He works with paediatricians, sports physiotherapists, sports physicians, and orthopaedic specialists under one roof to provide the best care for his patients. He recently completed his PhD addressing the impact of podiatry on patients with symptomatic hypermobility. He has three first author publications and recently published the first paper internationally looking at the use of custom-made orthotics in joint hypermobile children and adolescents. Mo has spoken at a number of national and international conferences on hypermobility and is a member of the Ehlers-Danlos Society International Consortium.

Mo spends his time between working, sport and looking after his 10-month-old son Malik.



Important Information:

  • If you are not an APP member (Australian Paediatrics Podiatry) you can add this membership to your APodA membership by joining here
  • APodA webinars are recorded and are available for APP members to view at any time at no cost.
  • Access the APP library from the APP Members page in the Member Resource section under the Special Interest Group tab.
  • Members can log this activity in the CPD portal to track their CPD activity for the year.
  • To access the CPD portal click on Member Centre and using the menu on the left, click on My CPD
  • Only participants who attend the case study webinar by logging in to the Zoom link provided and are actively online are issued with a certificate of attendance. Certificates will be issued within 7 - 10 business days after the event
  • CPD Terms and Conditions

Event Details

When:

Wednesday 30 October 2024

Where:

Webinar (online)

Time:

7:00pm - VIC, TAS, NSW, ACT (AEDT)
6:30pm - SA
6:00pm - QLD
5:30pm - NT
4:00pm - WA

Cost:

Free for APP Members and Student Members | $20 for APodA Members | $100 Non-Members

CPD Hours:

1 hour Category 1 Professional Development

Contact:

Australian Podiatry Association
info@podiatry.org.au
03 9416 3111

Register